Recapitulating the Pharmacological Interactions of Cetuximab with Sunitinib and Cisplatin in Head and Neck Carcinoma Cells in vitro

INTRODUCTION: Cisplatin is extensively used in the treatment of head and neck carcinomas. Cetuximab combination therapy is employed in recurrent and metastatic settings. Sunitinib showed positive results in the treatment of head and neck carcinomas, both as monotherapy or in combination with cetuxim...

Descripción completa

Detalles Bibliográficos
Autores principales: Dib, Maria, Justian, Nathanil, Scharf, Christian, Busch, Chia-Jung, Burchardt, Martin, Caetano-Pinto, Pedro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811422/
https://www.ncbi.nlm.nih.gov/pubmed/36273461
http://dx.doi.org/10.1159/000527082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811422/
https://www.ncbi.nlm.nih.gov/pubmed/36273461
http://dx.doi.org/10.1159/000527082

Ejemplares similares